Institutional Investors Increase AstraZeneca Holdings in Q3 2025
Multiple institutional investors expanded their positions in AstraZeneca during the third quarter of 2025, with several funds increasing holdings by over 100% according to SEC filings.
WallStreetZen
CompanyAlso known as: Wall Street Zen
Company Profile
WallStreetZen is a stock research platform designed for independent and part-time investors. The company says its product combines automated due-diligence checks, concise explanations, and visualizations to help users evaluate stocks more efficiently. Its distributed team reports a presence across multiple cities including Hong Kong, Osaka, Austin, and Barcelona.
- Website
- https://www.wallstreetzen.com
- Headquarters
- Kennedy Town, Hong Kong
Related News
Institutional Investors Increase AstraZeneca Holdings in Q3 2025
Multiple institutional investors expanded their stakes in AstraZeneca during the third quarter of 2025, with the stock trading near its 52-week high and maintaining a "Moderate Buy" rating from analysts.
Institutional Investors Adjust AstraZeneca Holdings in Q3
Multiple institutional investors modified their positions in AstraZeneca during the third quarter, with new stakes and adjustments reported in SEC filings. The company announced a dividend of $1.595 per share payable March 23rd.
Moderna Beats Q4 Estimates Amid FDA Flu Vaccine Setback
Moderna reported Q4 revenue of $678 million, beating analyst estimates, while posting a narrower-than-expected loss of $2.11 per share. The results came as the FDA refused to review the company's mRNA flu vaccine application.